Literature DB >> 12915938

Electrophoretic determination of the myosin/actin ratio in the diagnosis of critical illness myopathy.

Helena Stibler1, Lars Edström, Karsten Ahlbeck, Sten Remahl, Tor Ansved.   

Abstract

OBJECTIVE: To develop a rapid method to quantify myosin in muscle biopsy specimens from patients with critical illness myopathy (CIM).
DESIGN: Percutaneous muscle biopsy specimens at different stages of CIM were examined by light microscopy and transmission electron microscopy (TEM) and by horizontal pore gradient SDS electrophoresis (SDS-PAGE). The myosin/actin ratio was calculated densitometrically. Neurophysiological examinations were performed at various times during the course of CIM.
SETTING: All patients were treated in intensive care units at Karolinska Hospital. PATIENTS AND PARTICIPANTS: We studied 11 patients with CIM, 5 patients with axonal neuropathies, and 42 control individuals. MEASUREMENTS AND
RESULTS: The histopathological changes included in all cases muscle fiber atrophy, degeneration, regeneration, nuclear changes, and reduction in myofibrillar ATPase activity in both type I and II fibers. In severely affected muscles fiber type differentiation was lost. On TEM preferential loss of thick filaments was the dominant finding. In some patients changes were present only in parts of the specimen. The neurophysiological examinations indicated myopathy in five patients and combined myopathy and neuropathy in five and suggested neuropathy in one. The SDS-pore PAGE used showed a technical variation of 4-5%. Quantitative results were obtained within 1 day and night. The mean value of the myosin/actin ratio in controls was 1.37+/-0.21 and in CIM patients 0.37+/-0.17, without overlapping with the control values.
CONCLUSIONS: Considering the diagnostic difficulty using morphological and neurophysiological methods, especially in early stages of CIM, we suggest including SDS-pore PAGE to determine the myosin/actin ratio for rapid diagnosis of CIM.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12915938     DOI: 10.1007/s00134-003-1894-9

Source DB:  PubMed          Journal:  Intensive Care Med        ISSN: 0342-4642            Impact factor:   17.440


  25 in total

1.  Critical illness myopathy.

Authors:  D Lacomis; D W Zochodne; S J Bird
Journal:  Muscle Nerve       Date:  2000-12       Impact factor: 3.217

2.  Analysis of muscle proteins in acute quadriplegic myopathy.

Authors:  N Matsumoto; T Nakamura; Y Yasui; J Torii
Journal:  Muscle Nerve       Date:  2000-08       Impact factor: 3.217

3.  Muscle fiber types: how many and what kind?

Authors:  M H Brooke; K K Kaiser
Journal:  Arch Neurol       Date:  1970-10

4.  Acute necrotizing myopathy of intensive care: electrophysiological studies.

Authors:  D W Zochodne; D A Ramsay; V Saly; S Shelley; S Moffatt
Journal:  Muscle Nerve       Date:  1994-03       Impact factor: 3.217

5.  Critical care myopathy: an electrophysiological and histological study.

Authors:  M W Faragher; B J Day; X Dennett
Journal:  Muscle Nerve       Date:  1996-04       Impact factor: 3.217

6.  Acute quadriplegia and loss of muscle myosin in patients treated with nondepolarizing neuromuscular blocking agents and corticosteroids: mechanisms at the cellular and molecular levels.

Authors:  L Larsson; X Li; L Edström; L I Eriksson; H Zackrisson; C Argentini; S Schiaffino
Journal:  Crit Care Med       Date:  2000-01       Impact factor: 7.598

7.  Electrophysiologic studies in critical illness associated weakness: myopathy or neuropathy--a reappraisal.

Authors:  W Trojaborg; L H Weimer; A P Hays
Journal:  Clin Neurophysiol       Date:  2001-09       Impact factor: 3.708

8.  Acute quadriplegic myopathy: a complication of treatment with steroids, nondepolarizing blocking agents, or both.

Authors:  M Hirano; B R Ott; E C Raps; C Minetti; L Lennihan; N P Libbey; E Bonilla; A P Hays
Journal:  Neurology       Date:  1992-11       Impact factor: 9.910

9.  Patterns of neurophysiological abnormality in prolonged critical illness.

Authors:  J H Coakley; K Nagendran; G D Yarwood; M Honavar; C J Hinds
Journal:  Intensive Care Med       Date:  1998-08       Impact factor: 17.440

10.  Muscle is electrically inexcitable in acute quadriplegic myopathy.

Authors:  M M Rich; J W Teener; E C Raps; D L Schotland; S J Bird
Journal:  Neurology       Date:  1996-03       Impact factor: 9.910

View more
  13 in total

Review 1.  Intensive care unit-related generalized neuromuscular weakness due to critical illness polyneuropathy/myopathy in critically ill patients.

Authors:  Efstratios Apostolakis; Nikolaos A Papakonstantinou; Nikolaos G Baikoussis; George Papadopoulos
Journal:  J Anesth       Date:  2014-07-01       Impact factor: 2.078

Review 2.  The Sick and the Weak: Neuropathies/Myopathies in the Critically Ill.

Authors:  O Friedrich; M B Reid; G Van den Berghe; I Vanhorebeek; G Hermans; M M Rich; L Larsson
Journal:  Physiol Rev       Date:  2015-07       Impact factor: 37.312

3.  High dose methylprednisolone counteracts the negative effects of rocuronium on diaphragm function.

Authors:  Karen Maes; Dries Testelmans; Debby Thomas; Marc Decramer; Ghislaine Gayan-Ramirez
Journal:  Intensive Care Med       Date:  2011-08-18       Impact factor: 17.440

4.  Upregulation of the CaV 1.1-ryanodine receptor complex in a rat model of critical illness myopathy.

Authors:  Susan D Kraner; Qingbo Wang; Kevin R Novak; Dongmei Cheng; David R Cool; Junmin Peng; Mark M Rich
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2011-04-06       Impact factor: 3.619

Review 5.  [Critical illness myopathy in intensive care patients. Pathogenetic concepts and clinical management].

Authors:  O Friedrich; E Hund
Journal:  Anaesthesist       Date:  2006-12       Impact factor: 1.041

6.  Myofibrillar protein and gene expression in acute quadriplegic myopathy.

Authors:  Holly Norman; Håkan Zackrisson; Yvette Hedström; Per Andersson; Jenny Nordquist; Lars I Eriksson; Rolf Libelius; Lars Larsson
Journal:  J Neurol Sci       Date:  2009-06-06       Impact factor: 3.181

7.  Muscle paralysis and myosin loss in a patient with cancer cachexia.

Authors:  V Banduseela; J Ochala; K Lamberg; H Kalimo; L Larsson
Journal:  Acta Myol       Date:  2007-12

8.  Simplified electrophysiological evaluation of peripheral nerves in critically ill patients: the Italian multi-centre CRIMYNE study.

Authors:  Nicola Latronico; Guido Bertolini; Bruno Guarneri; Marco Botteri; Elena Peli; Serena Andreoletti; Paola Bera; Davide Luciani; Anna Nardella; Elena Vittorielli; Bruno Simini; Andrea Candiani
Journal:  Crit Care       Date:  2007       Impact factor: 9.097

Review 9.  Clinical review: Critical illness polyneuropathy and myopathy.

Authors:  Greet Hermans; Bernard De Jonghe; Frans Bruyninckx; Greet Van den Berghe
Journal:  Crit Care       Date:  2008-11-25       Impact factor: 9.097

10.  Critical illness polyneuropathy and myopathy: a systematic review.

Authors:  Chunkui Zhou; Limin Wu; Fengming Ni; Wei Ji; Jiang Wu; Hongliang Zhang
Journal:  Neural Regen Res       Date:  2014-01-01       Impact factor: 5.135

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.